πŸ‡ΊπŸ‡Έ FDA
Patent

US 9839625

Inhibition of cancer cell motility

granted A61KA61K31/167A61K31/353

Quick answer

US patent 9839625 (Inhibition of cancer cell motility) held by Northwestern University expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/167, A61K31/353, A61K31/4188, A61K45/06